Annual EBITDA
$93.07 M
-$37.15 M-28.53%
30 December 2023
Summary:
USANA Health Sciences annual earnings before interest, taxes, depreciation & amortization is currently $93.07 million, with the most recent change of -$37.15 million (-28.53%) on 30 December 2023. During the last 3 years, it has fallen by -$107.89 million (-53.69%). USNA annual EBITDA is now -55.34% below its all-time high of $208.39 million, reached on 29 December 2018.USNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$18.66 M
-$7.30 M-28.12%
30 September 2024
Summary:
USANA Health Sciences quarterly earnings before interest, taxes, depreciation & amortization is currently $18.66 million, with the most recent change of -$7.30 million (-28.12%) on 30 September 2024. Over the past year, it has dropped by -$7.08 million (-27.50%). USNA quarterly EBITDA is now -68.84% below its all-time high of $59.88 million, reached on 30 June 2021.USNA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$108.49 M
-$7.08 M-6.12%
30 September 2024
Summary:
USANA Health Sciences TTM earnings before interest, taxes, depreciation & amortization is currently $108.49 million, with the most recent change of -$7.08 million (-6.12%) on 30 September 2024. Over the past year, it has dropped by -$11.08 million (-9.27%). USNA TTM EBITDA is now -50.67% below its all-time high of $219.90 million, reached on 30 June 2021.USNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
USNA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.5% | -27.5% | -9.3% |
| 3 y3 years | -53.7% | -59.3% | -49.4% |
| 5 y5 years | -55.3% | -55.1% | -38.2% |
USNA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -53.7% | at low | -59.3% | at low | -49.4% | at low |
| 5 y | 5 years | -55.3% | at low | -68.8% | at low | -50.7% | at low |
| alltime | all time | -55.3% | +2349.2% | -68.8% | -50.7% |
USANA Health Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $18.66 M(-28.1%) | $108.49 M(-6.1%) |
| June 2024 | - | $25.96 M(-19.5%) | $115.56 M(-5.0%) |
| Mar 2024 | - | $32.25 M(+2.0%) | $121.60 M(-1.2%) |
| Dec 2023 | $93.07 M(-28.5%) | $31.63 M(+22.9%) | $123.11 M(+3.0%) |
| Sept 2023 | - | $25.73 M(-19.6%) | $119.57 M(-2.4%) |
| June 2023 | - | $31.99 M(-5.2%) | $122.52 M(-2.0%) |
| Mar 2023 | - | $33.76 M(+20.2%) | $125.05 M(-4.0%) |
| Dec 2022 | $130.22 M(-32.5%) | $28.09 M(-2.1%) | $130.22 M(-6.6%) |
| Sept 2022 | - | $28.68 M(-16.9%) | $139.46 M(-11.0%) |
| June 2022 | - | $34.53 M(-11.3%) | $156.63 M(-13.9%) |
| Mar 2022 | - | $38.92 M(+4.3%) | $181.99 M(-5.7%) |
| Dec 2021 | $192.89 M(-4.0%) | $37.33 M(-18.6%) | $192.89 M(-10.1%) |
| Sept 2021 | - | $45.85 M(-23.4%) | $214.51 M(-2.5%) |
| June 2021 | - | $59.88 M(+20.2%) | $219.90 M(+6.8%) |
| Mar 2021 | - | $49.83 M(-15.5%) | $205.86 M(+2.4%) |
| Dec 2020 | $200.96 M(+15.8%) | $58.94 M(+15.0%) | $200.96 M(+3.8%) |
| Sept 2020 | - | $51.24 M(+11.8%) | $193.57 M(+5.3%) |
| June 2020 | - | $45.85 M(+2.0%) | $183.89 M(+4.3%) |
| Mar 2020 | - | $44.93 M(-12.8%) | $176.31 M(+1.6%) |
| Dec 2019 | $173.57 M(-16.7%) | $51.55 M(+24.0%) | $173.57 M(-1.2%) |
| Sept 2019 | - | $41.56 M(+8.6%) | $175.60 M(-4.9%) |
| June 2019 | - | $38.26 M(-9.3%) | $184.62 M(-8.6%) |
| Mar 2019 | - | $42.20 M(-21.3%) | $202.05 M(-3.0%) |
| Dec 2018 | $208.39 M(+38.2%) | $53.58 M(+5.9%) | $208.39 M(+6.6%) |
| Sept 2018 | - | $50.58 M(-9.2%) | $195.53 M(+7.9%) |
| June 2018 | - | $55.69 M(+14.8%) | $181.14 M(+11.5%) |
| Mar 2018 | - | $48.53 M(+19.2%) | $162.48 M(+7.8%) |
| Dec 2017 | $150.80 M(-1.1%) | $40.72 M(+12.5%) | $150.80 M(+3.7%) |
| Sept 2017 | - | $36.19 M(-2.3%) | $145.42 M(-2.1%) |
| June 2017 | - | $37.04 M(+0.5%) | $148.55 M(-2.6%) |
| Mar 2017 | - | $36.84 M(+4.2%) | $152.59 M(+0.1%) |
| Dec 2016 | $152.48 M(-0.1%) | $35.35 M(-10.1%) | $152.48 M(-1.9%) |
| Sept 2016 | - | $39.32 M(-4.3%) | $155.37 M(-1.1%) |
| June 2016 | - | $41.08 M(+11.8%) | $157.11 M(+0.1%) |
| Mar 2016 | - | $36.73 M(-3.9%) | $157.02 M(+2.9%) |
| Dec 2015 | $152.58 M(+22.5%) | $38.24 M(-6.9%) | $152.58 M(+2.6%) |
| Sept 2015 | - | $41.06 M(+0.2%) | $148.65 M(+7.1%) |
| June 2015 | - | $40.99 M(+26.9%) | $138.82 M(+7.3%) |
| Mar 2015 | - | $32.29 M(-5.9%) | $129.42 M(+3.9%) |
| Dec 2014 | $124.59 M(-0.8%) | $34.31 M(+9.8%) | $124.59 M(+2.7%) |
| Sept 2014 | - | $31.24 M(-1.1%) | $121.37 M(+3.6%) |
| June 2014 | - | $31.58 M(+15.0%) | $117.14 M(-5.7%) |
| Mar 2014 | - | $27.46 M(-11.6%) | $124.25 M(-1.1%) |
| Dec 2013 | $125.63 M(+17.1%) | $31.08 M(+15.1%) | $125.63 M(+0.4%) |
| Sept 2013 | - | $27.01 M(-30.2%) | $125.11 M(+0.6%) |
| June 2013 | - | $38.70 M(+34.2%) | $124.39 M(+10.0%) |
| Mar 2013 | - | $28.84 M(-5.7%) | $113.05 M(+5.4%) |
| Dec 2012 | $107.27 M(+24.8%) | $30.57 M(+16.3%) | $107.27 M(+8.5%) |
| Sept 2012 | - | $26.28 M(-4.0%) | $98.91 M(+5.6%) |
| June 2012 | - | $27.36 M(+18.7%) | $93.65 M(+4.6%) |
| Mar 2012 | - | $23.06 M(+3.9%) | $89.55 M(+4.2%) |
| Dec 2011 | $85.96 M(+11.8%) | $22.20 M(+5.6%) | $85.96 M(+1.7%) |
| Sept 2011 | - | $21.02 M(-9.6%) | $84.53 M(-0.1%) |
| June 2011 | - | $23.27 M(+19.5%) | $84.66 M(+6.2%) |
| Mar 2011 | - | $19.47 M(-6.3%) | $79.69 M(+3.7%) |
| Dec 2010 | $76.87 M(+31.1%) | $20.77 M(-1.8%) | $76.87 M(+4.9%) |
| Sept 2010 | - | $21.15 M(+15.6%) | $73.31 M(+11.0%) |
| June 2010 | - | $18.30 M(+9.9%) | $66.04 M(+4.7%) |
| Mar 2010 | - | $16.66 M(-3.2%) | $63.05 M(+7.5%) |
| Dec 2009 | $58.66 M | $17.21 M(+24.1%) | $58.66 M(+18.1%) |
| Sept 2009 | - | $13.87 M(-9.4%) | $49.68 M(-1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2009 | - | $15.31 M(+24.9%) | $50.29 M(-4.2%) |
| Mar 2009 | - | $12.26 M(+48.8%) | $52.50 M(-2.4%) |
| Dec 2008 | $53.81 M(-29.2%) | $8.24 M(-43.1%) | $53.81 M(-16.2%) |
| Sept 2008 | - | $14.48 M(-17.4%) | $64.23 M(-5.8%) |
| June 2008 | - | $17.53 M(+29.2%) | $68.17 M(-2.9%) |
| Mar 2008 | - | $13.57 M(-27.3%) | $70.20 M(-7.7%) |
| Dec 2007 | $76.03 M(+9.8%) | $18.65 M(+1.2%) | $76.03 M(+0.3%) |
| Sept 2007 | - | $18.43 M(-5.8%) | $75.80 M(+1.4%) |
| June 2007 | - | $19.56 M(+0.8%) | $74.77 M(+3.3%) |
| Mar 2007 | - | $19.40 M(+5.3%) | $72.36 M(+4.9%) |
| Dec 2006 | $69.26 M(+4.9%) | $18.42 M(+5.9%) | $68.95 M(-0.5%) |
| Sept 2006 | - | $17.40 M(+1.5%) | $69.29 M(+1.8%) |
| June 2006 | - | $17.14 M(+7.2%) | $68.03 M(+1.4%) |
| Mar 2006 | - | $15.99 M(-14.7%) | $67.11 M(+1.6%) |
| Dec 2005 | $66.04 M(-1.7%) | $18.76 M(+16.2%) | $66.04 M(-15.8%) |
| Sept 2005 | - | $16.14 M(-0.5%) | $78.40 M(+3.7%) |
| June 2005 | - | $16.22 M(+8.8%) | $75.57 M(+5.2%) |
| Mar 2005 | - | $14.92 M(-52.1%) | $71.81 M(+6.9%) |
| Dec 2004 | $67.18 M(+92.0%) | $31.12 M(+133.7%) | $67.18 M(+43.1%) |
| Sept 2004 | - | $13.31 M(+6.9%) | $46.95 M(+8.8%) |
| June 2004 | - | $12.46 M(+21.1%) | $43.14 M(+11.4%) |
| Mar 2004 | - | $10.29 M(-5.4%) | $38.73 M(+10.7%) |
| Dec 2003 | $35.00 M(+106.7%) | $10.88 M(+14.5%) | $35.00 M(+17.7%) |
| Sept 2003 | - | $9.51 M(+18.0%) | $29.73 M(+19.8%) |
| June 2003 | - | $8.05 M(+22.9%) | $24.82 M(+21.0%) |
| Mar 2003 | - | $6.56 M(+16.8%) | $20.50 M(+21.1%) |
| Dec 2002 | $16.93 M(+103.6%) | $5.61 M(+22.3%) | $16.93 M(+26.6%) |
| Sept 2002 | - | $4.59 M(+22.7%) | $13.38 M(+22.3%) |
| June 2002 | - | $3.74 M(+25.3%) | $10.94 M(+21.2%) |
| Mar 2002 | - | $2.99 M(+45.0%) | $9.03 M(+8.5%) |
| Dec 2001 | $8.32 M(-13.7%) | $2.06 M(-4.5%) | $8.32 M(+3.4%) |
| Sept 2001 | - | $2.15 M(+18.1%) | $8.04 M(-1.7%) |
| June 2001 | - | $1.82 M(-19.9%) | $8.18 M(-1.2%) |
| Mar 2001 | - | $2.28 M(+27.6%) | $8.28 M(-14.1%) |
| Dec 2000 | $9.64 M(-47.9%) | $1.78 M(-22.3%) | $9.64 M(-24.7%) |
| Sept 2000 | - | $2.30 M(+19.3%) | $12.80 M(-13.3%) |
| June 2000 | - | $1.93 M(-47.1%) | $14.76 M(-16.8%) |
| Mar 2000 | - | $3.64 M(-26.4%) | $17.74 M(-4.8%) |
| Dec 1999 | $18.50 M(-0.5%) | $4.94 M(+16.1%) | $18.63 M(+0.8%) |
| Sept 1999 | - | $4.26 M(-13.1%) | $18.48 M(-3.9%) |
| June 1999 | - | $4.90 M(+8.3%) | $19.23 M(0.0%) |
| Mar 1999 | - | $4.52 M(-5.8%) | $19.23 M(+3.3%) |
| Dec 1998 | $18.60 M(+45.3%) | $4.80 M(-4.0%) | $18.60 M(+3.9%) |
| Sept 1998 | - | $5.00 M(+2.0%) | $17.90 M(+9.1%) |
| June 1998 | - | $4.90 M(+25.6%) | $16.40 M(+13.9%) |
| Mar 1998 | - | $3.90 M(-4.9%) | $14.40 M(+12.5%) |
| Dec 1997 | $12.80 M(+47.1%) | $4.10 M(+17.1%) | $12.80 M(+21.9%) |
| Sept 1997 | - | $3.50 M(+20.7%) | $10.50 M(+10.5%) |
| June 1997 | - | $2.90 M(+26.1%) | $9.50 M(+3.3%) |
| Mar 1997 | - | $2.30 M(+27.8%) | $9.20 M(+4.5%) |
| Dec 1996 | $8.70 M(+128.9%) | $1.80 M(-28.0%) | $8.80 M(+4.8%) |
| Sept 1996 | - | $2.50 M(-3.8%) | $8.40 M(+21.7%) |
| June 1996 | - | $2.60 M(+36.8%) | $6.90 M(-33.7%) |
| Mar 1996 | - | $1.90 M(+35.7%) | $10.40 M(-28.8%) |
| Dec 1995 | $3.80 M(-47.9%) | $1.40 M(+40.0%) | $14.60 M(-3.9%) |
| Sept 1995 | - | $1.00 M(-83.6%) | $15.20 M(-5.6%) |
| June 1995 | - | $6.10 M(0.0%) | $16.10 M(+36.4%) |
| Mar 1995 | - | $6.10 M(+205.0%) | $11.80 M(+107.0%) |
| Dec 1994 | $7.30 M | $2.00 M(+5.3%) | $5.70 M(+54.1%) |
| Sept 1994 | - | $1.90 M(+5.6%) | $3.70 M(+105.6%) |
| June 1994 | - | $1.80 M(>+9900.0%) | $1.80 M(>+9900.0%) |
| Mar 1994 | - | $0.00 | $0.00 |
FAQ
- What is USANA Health Sciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for USANA Health Sciences?
- What is USANA Health Sciences annual EBITDA year-on-year change?
- What is USANA Health Sciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for USANA Health Sciences?
- What is USANA Health Sciences quarterly EBITDA year-on-year change?
- What is USANA Health Sciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for USANA Health Sciences?
- What is USANA Health Sciences TTM EBITDA year-on-year change?
What is USANA Health Sciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of USNA is $93.07 M
What is the all time high annual EBITDA for USANA Health Sciences?
USANA Health Sciences all-time high annual earnings before interest, taxes, depreciation & amortization is $208.39 M
What is USANA Health Sciences annual EBITDA year-on-year change?
Over the past year, USNA annual earnings before interest, taxes, depreciation & amortization has changed by -$37.15 M (-28.53%)
What is USANA Health Sciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of USNA is $18.66 M
What is the all time high quarterly EBITDA for USANA Health Sciences?
USANA Health Sciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is $59.88 M
What is USANA Health Sciences quarterly EBITDA year-on-year change?
Over the past year, USNA quarterly earnings before interest, taxes, depreciation & amortization has changed by -$7.08 M (-27.50%)
What is USANA Health Sciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of USNA is $108.49 M
What is the all time high TTM EBITDA for USANA Health Sciences?
USANA Health Sciences all-time high TTM earnings before interest, taxes, depreciation & amortization is $219.90 M
What is USANA Health Sciences TTM EBITDA year-on-year change?
Over the past year, USNA TTM earnings before interest, taxes, depreciation & amortization has changed by -$11.08 M (-9.27%)